blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability
Register Forum

2022.02.11

More...
blank News flashes

News Flashes

New version of the European Patent Register – SPC proceedings information in the Unitary Patent Register.

2024-07-24

More...
blank Related links

Extract from the Register of European Patents

EP About this file: EP1579859

EP1579859 - Use of N-(2-aryl-propionyl)-sulfonamides for the treatment of spinal cord injury [Right-click to bookmark this link]
StatusNo opposition filed within time limit
Status updated on  19.10.2007
Database last updated on 26.07.2024
Most recent event   Tooltip19.10.2007No opposition filed within time limitpublished on 21.11.2007  [2007/47]
Applicant(s)For all designated states
DOMPE' pha.r.ma S.p.A.
Via Campo di Pile
67100 L'Aquila / IT
[2006/32]
Former [2005/39]For all designated states
Dompe' S.P.A.
Via Campo di Pile
67100 L'Aquila / IT
Inventor(s)01 / Bertini, Riccardo
Via Campo di Pile
67100 L'Aquila / IT
02 / Colotta, Francesco
Via Campo di Pile
67100 L'Aquila / IT
 [2005/39]
Representative(s)Minoja, Fabrizio
Bianchetti & Minoja S.r.l.
Via Plinio, 63
20129 Milano / IT
[N/P]
Former [2005/39]Minoja, Fabrizio
Bianchetti Bracco Minoja S.r.l. Via Plinio, 63
20129 Milano / IT
Application number, filing date04007177.125.03.2004
[2005/39]
Filing languageEN
Procedural languageEN
PublicationType: A1 Application with search report 
No.:EP1579859
Date:28.09.2005
Language:EN
[2005/39]
Type: B1 Patent specification 
No.:EP1579859
Date:13.12.2006
Language:EN
[2006/50]
Search report(s)(Supplementary) European search report - dispatched on:EP02.09.2004
ClassificationIPC:A61K31/18, A61K31/38, A61K31/4035, A61P25/00
[2005/39]
CPC:
A61K31/18 (EP,KR,US); A61K31/38 (EP,US); A61K31/4035 (EP,US);
A61P25/00 (EP); A61P35/00 (EP)
Designated contracting statesAT,   BE,   BG,   CH,   CY,   CZ,   DE,   DK,   EE,   ES,   FI,   FR,   GB,   GR,   HU,   IE,   IT,   LI,   LU,   MC,   NL,   PL,   PT,   RO,   SE,   SI,   SK,   TR [2005/39]
Extension statesAL10.03.2006
LT10.03.2006
LV10.03.2006
MK10.03.2006
TitleGerman:Verwendung von N-(2-Aryl-propionyl)-sulfonamiden zur Behandlung von Rückenmarkverletzungen[2006/29]
English:Use of N-(2-aryl-propionyl)-sulfonamides for the treatment of spinal cord injury[2005/39]
French:Utilisation de N-(2-aryl-propionyl)-sulfonamides dans le traitement des lésions de la moelle épinière[2005/39]
Former [2005/39]Verwendung von N-(2-Aryl-Propionyl)-Sulfonamiden zur Behandlung von Rückenmarkverletzungen
Examination procedure10.03.2006Examination requested  [2006/18]
26.06.2006Communication of intention to grant the patent
11.10.2006Fee for grant paid
11.10.2006Fee for publishing/printing paid
Opposition(s)14.09.2007No opposition filed within time limit [2007/47]
Fees paidRenewal fee
22.03.2006Renewal fee patent year 03
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court
See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Documents cited:Search[DY]EP1123276  (DOMPE SPA) [DY] 1-4 * page 2, paragraph 1 - paragraph 6 * * page 3, paragraph 16 - page 4, paragraph 23 * * page 6, paragraphs 33,39 * * page 7, paragraph 45 * * example 1 * * claims 1-8,10-12 *;
 [Y]US2001016195  (TOBINICK EDWARD L [US]) [Y] 1-4 * page 1, paragraph 2 * * page 2, paragraph 19 * * page 2, paragraph 29 - page 3, paragraph 30 * * page 3, paragraphs 36,38-40 * * page 4, paragraph 52 * * page 5, paragraph 66 - paragraph 68 ** claims 24,25,28 *;
 [Y]WO0179189  (DOMPE SPA [IT], et al) [Y] 1,2 * page 1, line 5 - line 8 * * page 2, line 4 - line 12 * * page 4, line 7 - line 17 * * page 6, line 1 - page 7, line 3 * * page 15, line 9 - line 11 * * claims 1,8,10 *;
 [Y]WO02062330  (DOMPE SPA [IT], et al) [Y] 1-4 * page 2, line 9 - line 17 * * example 1 * * claims 1,3,4,7,8 *;
 [Y]  - LI J J, "Small molecule interleukin-8 modulators", EXPERT OPINION ON THERAPEUTIC PATENTS 2001 UNITED KINGDOM, (2001), vol. 11, no. 12, ISSN 1354-3776, pages 1905 - 1910, XP001079136 [Y] 1-4 * abstract * * page 1905, paragraph 1 * * compound 16 * * page 1907, column 2, paragraph 2 *

DOI:   http://dx.doi.org/10.1517/13543776.11.12.1905
 [Y]  - SCHNELL L ET AL, "Neutrophil-mediated axonal damage in the adult rat spinal cord", SOCIETY FOR NEUROSCIENCE ABSTRACTS, & 31ST ANNUAL MEETING OF THE SOCIETY FOR NEUROSCIENCE; SAN DIEGO, CALIFORNIA, USA; NOVEMBER 10-15, 2001, (2001), vol. 27, no. 2, ISSN 0190-5295, page 1835, XP001199809 [Y] 1-4 * the whole document *
 [Y]  - XU J ET AL, "POLYMORPHONUCLEAR PMN CELL INFILTRATION IN EXPERIMENTAL SPINAL CORD INJURY", SOCIETY FOR NEUROSCIENCE ABSTRACTS, & 17TH ANNUAL MEETING OF THE SOCIETY FOR NEUROSCIENCE, NEW ORLEANS, LOUISIANA, USA, NOVEMBER 16-21, 19, (1987), vol. 13, no. 3, ISSN 0190-5295, page 1500, XP008034241 [Y] 1-4 * the whole document *
 [Y]  - ISAKSSON JONAS ET AL, "Expression of ICAM-1 and CD11b after experimental spinal cord injury in rats", JOURNAL OF NEUROTRAUMA, (199902), vol. 16, no. 2, ISSN 0897-7151, pages 165 - 173, XP008034243 [Y] 1-4 * abstract * * page 165, column 1, paragraph 1 - column 2, paragraph 1 * * page 171, column 1, paragraph 1 *
 [Y]  - CALVILLO LAURA ET AL, "Reduction of ischemia-reperfusion injury in the rat in vivo by DF1681A, an inhibitor of interleukin-8", JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, & 50TH ANNUAL SCIENTIFIC SESSION OF THE AMERICAN COLLEGE OF CARDIOLOGY; ORLANDO, FLORIDA, USA; MARCH 18-21, 2001, (200102), vol. 37, no. 2 Supplement A, ISSN 0735-1097, page 374A, XP001199808 [Y] 1-4 * the whole document *
 [Y]  - KUNIHARA T ET AL, "Proinflammatory cytokines in cerebrospinal fluid in repair of thoracoabdominal aorta", ANNALS OF THORACIC SURGERY 2001 UNITED STATES, (2001), vol. 71, no. 3, ISSN 0003-4975, pages 801 - 806, XP001199810 [Y] 1-4 * abstract * * page 801, column 1, paragraph 1 - column 2, paragraph 1 * * page 804, column 2, paragraph 1 * * page 805, column 2, paragraph 2 * * page 806, column 1, paragraph 3 *

DOI:   http://dx.doi.org/10.1016/S0003-4975(00)02441-3
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.